Guide to paying a small fine and making billions

Related image
graphic source: encongnitive.com

The key factor is: be a drug company.
In this case, Celgene. Their drugs are Thalomid and Revlimid. 

(...)

A long-running suit against Celgene, launched by Beverly Brown, who used to be the company’s sales manager, contends that: 

Celgene trained its sales team to promote off-label uses to doctors; Celgene sales people intentionally lied about studies, claiming the studies showed the off-label uses were beneficial to patients; And the company omitted vital warnings about the drugs’ uses from the drugs’ labels.



No comments: